Market Access How new PBM transparency rules will alter drug pricing The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.
R&D European launch: Manufacturing as cornerstone for success In Europe, manufacturing may not make headlines in pharma partnering, but it’s one of the foundations on which strong partnerships must be built.
R&D How medical supply chains are adapting to global disruptions From the lingering impacts of pandemic-era bottlenecks to geopolitical tensions and extreme weather events, medical supply chains are under pressure.
Event Partner Content PHARMAP 2026: Where Pharma Meets Policy The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2026)
Patients Meeting the growing demand for animal-free medicines Pharmaceutical manufacturers have begun, albeit tentatively, to acknowledge and respond to evolving dietary sensibilities.
R&D Simplicity wins: How Lean principles and smart automation ca... Manufacturers truly outperforming their peers share a defining trait: a ruthless commitment to simplicity, based on Lean principles and automation.
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.